abagovomab - CISMeF

" /> abagovomab - CISMeF

CISMeF

chu

AbagovomabMeSH Supplementary Concept

Preferred Label : abagovomab;

MeSH note : murine anti-idiotypic antibody against the antigen CA-125 which has been shown to elicit humoral and cellular immune responses against recurrent ovarian cancer;

MeSH hyponym : ACA125;

Is substance : O;

UNII : 3YK0326U7X;

Détails

Origin ID

C518318;

UMLS CUI

C1832044;

Currated CISMeF NLP mapping
- Abagovomab [NCIt concept]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
- antibodies, monoclonal, Murine-Derived [MeSH Descriptor]
Pharmacological action(s)
- Antineoplastic Agents, Immunological [MeSH Descriptor]
Record concept(s)
- ACA-125 [MeSH concept]
- MEN-2234 [MeSH concept]
- abagovomab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Abagovomab [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients

Nous contacter.
27/07/2025

[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.

" /> abagovomab - CISMeF

CISMeF

chu

AbagovomabMeSH Supplementary Concept

Preferred Label : abagovomab;

MeSH note : murine anti-idiotypic antibody against the antigen CA-125 which has been shown to elicit humoral and cellular immune responses against recurrent ovarian cancer;

MeSH hyponym : ACA125;

Is substance : O;

UNII : 3YK0326U7X;

Détails

Origin ID

C518318;

UMLS CUI

C1832044;

Currated CISMeF NLP mapping
- Abagovomab [NCIt concept]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
- antibodies, monoclonal, Murine-Derived [MeSH Descriptor]
Pharmacological action(s)
- Antineoplastic Agents, Immunological [MeSH Descriptor]
Record concept(s)
- ACA-125 [MeSH concept]
- MEN-2234 [MeSH concept]
- abagovomab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Abagovomab [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients

Nous contacter.
27/07/2025

[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.